Biomarkers are becoming an essential part of drug discovery and developmental processes in pharmaceutical research. They serve as diagnostic tools for patient selection, surrogate endpoints in clinical trials or development of personalized therapies. Modern technology, high-dimensional data and specific issues present challenges in the statistical analysis of biomarker data.
Chrestos supports you in the planning of the trial to the statistical analysis to the interpretation and communication of the results.
Our team creates high-quality result reports, data visualizations and presentations. Moreover, we support you in communicating and presenting the results in interdisciplinary teams and in drawing up scientific publications.
You can benefit from our profound biostatistical and bioinformatic expertise in standardized- and individual analyses. Our biomarker statisticians are experienced in pre-clinical studies, clinical studies from phases I to III and non-clinical studies. Our team is familiar with a lot of different measuring technologies (among other things RT-qPCR, RNAseq, gene expression arrays) and quarantees up to date performance through expert training.